Unity Biotechnology, Inc. Operating Lease, Expense
Unity Biotechnology, Inc. reported Operating Lease, Expense of $461.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2022-03-15
- Unity Biotechnology, Inc. operating lease, expense for the quarter ending 2020-03-31 was $461.00K, a 15.25% increase year-over-year.
- Unity Biotechnology, Inc. operating lease, expense for the quarter ending 2019-12-31 was $1.50M.
- Unity Biotechnology, Inc. operating lease, expense for the quarter ending 2019-09-30 was $1.50M.
- Unity Biotechnology, Inc. operating lease, expense for the quarter ending 2019-06-30 was $1.10M.
- Unity Biotechnology, Inc. operating lease, expense for fiscal 2019 was $4.50M, a 150.00% increase from fiscal 2018.
- Unity Biotechnology, Inc. operating lease, expense for fiscal 2018 was $1.80M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2020-03-31 | $461.00K 10-Q · filed 2020-05-07 | $1.96M derived: sum of 2 quarters · filed 2022-03-15 | $3.46M derived: sum of 3 quarters · filed 2022-03-15 | $4.56M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $3.00M derived: sum of 2 quarters · filed 2022-03-15 | $4.10M derived: sum of 3 quarters · filed 2022-03-15 | $4.50M 10-K · filed 2022-03-15 |
| 2019-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $2.60M derived: sum of 2 quarters · filed 2020-11-04 | $3.00M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $1.50M 10-Q · filed 2020-07-31 | ||
| 2019-03-31 | $400.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $1.80M 10-K · filed 2021-03-23 |